Securian Asset Management Inc. Sells 208 Shares of Encompass Health Co. (NYSE:EHC)

Securian Asset Management Inc. cut its stake in shares of Encompass Health Co. (NYSE:EHC) by 2.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,616 shares of the company’s stock after selling 208 shares during the quarter. Securian Asset Management Inc.’s holdings in Encompass Health were worth $703,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also bought and sold shares of EHC. MassMutual Private Wealth & Trust FSB lifted its position in Encompass Health by 87.8% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after purchasing an additional 137 shares during the last quarter. Avior Wealth Management LLC bought a new stake in shares of Encompass Health in the 3rd quarter worth approximately $40,000. Tompkins Financial Corp bought a new stake in shares of Encompass Health in the 4th quarter worth approximately $46,000. V Square Quantitative Management LLC lifted its holdings in shares of Encompass Health by 43.8% in the 4th quarter. V Square Quantitative Management LLC now owns 581 shares of the company’s stock worth $54,000 after acquiring an additional 177 shares during the last quarter. Finally, Morse Asset Management Inc bought a new stake in shares of Encompass Health in the 3rd quarter worth approximately $68,000. 97.25% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

EHC has been the subject of a number of recent research reports. Barclays boosted their price objective on shares of Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, February 7th. StockNews.com upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a report on Saturday, February 15th. Royal Bank of Canada restated an “outperform” rating and issued a $110.00 price objective on shares of Encompass Health in a report on Tuesday, February 11th. KeyCorp lifted their target price on shares of Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a research note on Monday, February 10th. Finally, William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a research note on Friday, February 7th. Ten equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $107.67.

Encompass Health Stock Up 2.6 %

Shares of Encompass Health stock opened at $96.11 on Monday. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.84. The company’s fifty day simple moving average is $97.35 and its two-hundred day simple moving average is $96.97. The company has a market cap of $9.68 billion, a P/E ratio of 21.55, a PEG ratio of 2.31 and a beta of 0.92. Encompass Health Co. has a 12-month low of $74.45 and a 12-month high of $104.55.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. Research analysts anticipate that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.71%. The ex-dividend date is Tuesday, April 1st. Encompass Health’s payout ratio is currently 15.25%.

Insider Transactions at Encompass Health

In other news, CAO Andrew L. Price sold 5,042 shares of the company’s stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the sale, the chief accounting officer now directly owns 69,164 shares of the company’s stock, valued at $6,798,129.56. This represents a 6.79 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 2.10% of the company’s stock.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.